CK Regeon at Cosmoprof Asia 2026

November 20, 2026

Back in Hong Kong: CK Regeon at Cosmoprof Asia 2026

For the second year in a row, CK Regeon brought its DermaRegeon scalp care brands, HERIBON and HAIRREGEON, to Cosmoprof Asia in Hong Kong. Over three days, our team met buyers and partners from more than 20 countries at our booth.

  • Dates: 11–13 November 2026
  • Venue: Hong Kong Convention and Exhibition Centre (HKCEC)
  • Our booth: Hall 3G, 3G-K3J

This post looks back on the show, what we heard from visitors, and where we want to take our cosmetics business next.

A bigger, busier show

The 29th Cosmoprof Asia was larger than last year. Organizers reported 2,806 exhibitors from 43 countries and regions, up about 4%, with 21 national pavilions and more than 78,000 visitors expected across its two venues. Around 550 hosted buyers came from over 56 countries, including new delegations from the Middle East, Central Asia and Africa.

Three trends stood out on the floor, and all three point toward scalp and hair care:

  • Science-backed formulas. Buyers asked less about packaging and more about active ingredients, mechanism and clinical data.
  • Haircare moving up. Organizers named haircare as a category adopting more advanced formulations, alongside longevity and wellness.
  • Korea's clinical edge. Korean beauty was described as a source of clinical innovation, not only trends.

We felt this at our booth. Many visitors stopped because they wanted to understand how our products work, not just how they look.

At our booth: a truly global audience

Over three days, our booth welcomed buyers from more than 20 countries across Asia-Pacific, Europe, the Americas and the Middle East. Most were hair and beauty distributors, joined by retailers, brand owners, and salon and spa professionals.

Interest was strong across the whole portfolio, and most visitors wanted to learn about both brands. Many tried the products at the booth, and some bought HERIBON for their own use. Salon and clinic professionals saw HAIRREGEON as a clearly premium treatment, while several skincare distributors told us they are looking to expand into science-based scalp care.

We are now following up with each partner we met to turn these conversations into lasting business.

What we showed: two brands, one science

Both DermaRegeon brands come from CK Regeon's research on Wnt signaling, the pathway that drives hair follicle regeneration, developed with Yonsei University.

  • HAIRREGEON is a luxury, professional-only scalp care treatment for clinics and salons, built on the PTD-DBM peptide.
  • HERIBON is a 4-step home scalp care line (Scaler, Shampoo, Treatment and Tonic), built on KY19382.

Together they let a partner serve both channels: the professional treatment in the salon or clinic, and the daily routine at home.

Where we stand today

DermaRegeon is already sold beyond Korea, and our regulatory base is in place for further expansion.

  • Global presence: Germany, the Baltic States (Estonia, Latvia and Lithuania, under exclusive distribution), the USA, Canada, Hong Kong, Macao, Vietnam, Thailand, Malaysia, Egypt and Saudi Arabia.
  • Registrations: US MoCRA, EU CPNP and UK SCPN.
  • Certification: Dermatest (Germany).

Our drug pipeline is moving too. In October 2026, CK Regeon was selected for Korea's Deep-Tech TIPS program, a three-year, KRW 2.0 billion project to advance our hair loss candidate CKR-051 toward Phase 2. CKR-051 is built on the same WNT ON platform behind our DermaRegeon brands. Read the announcement.

Our ambition: drug-grade science for every scalp

CK Regeon is a drug developer first, and that is what makes our cosmetics different. We want DermaRegeon to be the global reference for science-based scalp care, carrying research from the lab into salons, clinics and homes.

Three goals guide the next stage:

  1. Build a partner network across regions. Hong Kong confirmed demand in Asia-Pacific, Europe and the Americas. We will turn these conversations into long-term distribution partnerships, market by market.
  2. Lead with evidence. As buyers ask more about mechanism and clinical data, we will keep sharing the science behind every product.
  3. Grow cosmetics and medicine together. Our scalp care brands and our hair loss drug pipeline share one platform. As CKR-051 moves toward Phase 2, we expect that research to keep strengthening the DermaRegeon story.

Thank you, Hong Kong

Thank you to everyone who visited booth 3G-K3J, tried our products and shared their market insights with us. We look forward to continuing these conversations.

If you distribute professional or home hair care and would like to partner with DermaRegeon, please contact us at dermaregeon@ckregeon.com or through our Business Partnership page.

Sources